Hinge Health (NYSE:HNGE) Coverage Initiated by Analysts at Canaccord Genuity Group

Analysts at Canaccord Genuity Group began coverage on shares of Hinge Health (NYSE:HNGE - Get Free Report) in a note issued to investors on Monday,Benzinga reports. The brokerage set a "buy" rating and a $52.00 price target on the stock. Canaccord Genuity Group's price objective would suggest a potential upside of 49.60% from the stock's previous close.

A number of other research analysts also recently commented on HNGE. Barclays began coverage on Hinge Health in a research note on Monday. They set an "overweight" rating and a $43.00 price objective for the company. Wall Street Zen raised Hinge Health to a "hold" rating in a research note on Monday, June 2nd. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $46.75.

Hinge Health Stock Down 0.7%

Shares of NYSE HNGE opened at $34.76 on Monday. Hinge Health has a 52-week low of $33.42 and a 52-week high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.